Your browser doesn't support javascript.
loading
Evidence of impaired bone quality in men with type 1 diabetes: a cross-sectional study.
Syversen, Unni; Mosti, Mats Peder; Mynarek, Ida Maria; Vedal, Trude Seselie Jahr; Aasarød, Kristin; Basso, Trude; Reseland, Janne E; Thorsby, Per Medbøe; Asvold, Bjorn O; Eriksen, Erik Fink; Stunes, Astrid Kamilla.
Afiliação
  • Syversen U; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Mosti MP; Department of Endocrinology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway.
  • Mynarek IM; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Vedal TSJ; Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway.
  • Aasarød K; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Basso T; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Reseland JE; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Thorsby PM; Department of Gastroenterology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway.
  • Asvold BO; Department of Orthopedics, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway.
  • Eriksen EF; Department of Biomaterials, University of Oslo, Oslo, Norway.
  • Stunes AK; Hormone Laboratory, Department of Medical Biochemistry, Oslo University Hospital, Aker, Oslo, Norway.
Endocr Connect ; 10(8): 955-964, 2021 Aug 13.
Article em En | MEDLINE | ID: mdl-34289447
ABSTRACT

OBJECTIVE:

Type 1 diabetes (T1D) is associated with substantial fracture risk. Bone mineral density (BMD) is, however, only modestly reduced, suggesting impaired bone microarchitecture and/or bone material properties. Yet, the skeletal abnormalities have not been uncovered. Men with T1D seem to experience a more pronounced bone loss than their female counterparts. Hence, we aimed to examine different aspects of bone quality in men with T1D. DESIGN AND

METHODS:

In this cross-sectional study, men with T1D and healthy male controls were enrolled. BMD (femoral neck, total hip, lumbar spine, whole body) and spine trabecular bone score (TBS) were measured by dual x-ray absorptiometry, and bone material strength index (BMSi) was measured by in vivo impact microindentation. HbA1c and bone turnover markers were analyzed.

RESULTS:

Altogether, 33 men with T1D (43 ± 12 years) and 28 healthy male controls (42 ± 12 years) were included. Subjects with T1D exhibited lower whole-body BMD than controls (P = 0.04). TBS and BMSi were attenuated in men with T1D vs controls (P = 0.016 and P = 0.004, respectively), and T1D subjects also had a lower bone turnover. The bone parameters did not differ between subjects with or without diabetic complications. Duration of disease correlated negatively with femoral neck BMD but not with TBS or BMSi.

CONCLUSIONS:

This study revealed compromised bone material strength and microarchitecture in men with T1D. Moreover, our data confirm previous studies which found a modest decrease in BMD and low bone turnover in subjects with T1D. Accordingly, bone should be recognized as a target of diabetic complications.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article